Artemisinin Partial Resistance in Ugandan Children With Complicated Malaria
This study assesses artemisinin partial resistance, Pfkelch13 variations, and malaria recrudescence in Ugandan children with complicated malaria.
Related Articles
AMA advocacy efforts for 2025: Fixing Medicare now, prior authorization reform and more
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about AMA’s advocacy efforts for 2025.
DOJ seeks interviews with former UnitedHealth Group doctors
UnitedHealth is the country’s largest health insurer and has 90,000 doctors under its control, more than any other company.
Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target – MedCity News
Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include…
Subha Madhavan on LinkedIn: Excited to share insights from our new review article published in…
Excited to share insights from our new review article published in Clinical & Translational Science! In this piece, Karthik Raman, Cynthia J. (CJ) Musante…
Why Abbott Labs, Dexcom ended glucose monitor patent fight
After years of back-and-forth litigation, both sides agreed to a 10-year truce. What changed?
Skechers Went After the Customers Nike Didn’t. It Paid Off.
Shoe company has focused on comfort over cool—‘we’re just a different player.’
Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money.
Navigating the world of artificial intelligence in health care
Artificial intelligence (AI) is rapidly transforming health care, offering exciting potential to enhance patient care and alleviate physician burdens, while raising critical concerns about ethics,…
Mayo Clinic Proceedings: Commemorating a Century of Continuous Communication
This issue of Mayo Clinic Proceedings is the first in Volume 100 of a medical journal that has been continuously published since April 21, 1926.…
